InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-30.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Vos Ellen O'Connor, Director. Insider active across 3 companies, notably OptimizeRx Corp. Aggregated, 17 filings have been recorded. Split: 3 buys · 0 sell. Total volume traded: €150k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Vos Ellen O'Connor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
9,868 shares0Common StockSEC:0001628280-25-031019:0
5,312 shares0Common StockSEC:0001641172-25-014017:0
5,313 shares0Common StockSEC:0001641172-25-002278:0
5,312 shares0Common StockSEC:0001562180-25-000277:0
5,313 shares0Common StockSEC:0001562180-24-007233:0
16,593 shares0Common StockSEC:0000950170-24-096244:0
3,268 sharesCommon StockSEC:0000950170-24-082709:0
10,061 shares0Common StockSEC:0001628280-24-027715:0
4,637 shares0Common StockSEC:0001628280-23-029926:0
3,769 shares@ US$3.98100.0% of flowCommon StockSEC:0000926617-23-000061:0
Canonical exit: 22 Oct 2023 (T+90)
29,109 shares0Common StockSEC:0001562180-23-004817:0
657 shares0Common StockSEC:0001628280-23-010319:0
409 shares0Common StockSEC:0001628280-23-000213:0
334 shares0Common StockSEC:0001628280-22-025807:0
500 shares@ US$15.91100.0% of flowCommon StockSEC:0001213900-22-049031:0
Canonical exit: 14 Nov 2022 (T+90)
55,555 shares@ US$2.70100.0% of flowCommon StockSEC:0001019056-21-000555:0
Canonical exit: 26 Jan 2022 (T+90)
407 shares0Common StockSEC:0001213900-21-035082:0
17 of 17 declarations
About Vos Ellen O'Connor
Vos Ellen O'Connor is Chief Executive Officer and Director. The file shows 17 filings in total, and across the 17 recent filings held, buys total 149764 EUR and sells total 0 EUR, between 2021-06-30 and 2025-06-12. The most common transaction nature is Option exercise, and the main recent filings concern Modular Medical, Inc., Aspira Women's Health Inc., and OptimizeRx Corp.
